Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib. - Manzanares M; Ramos-Martín F; Rodríguez-Mora S; Casado-Fernández G; Sánchez-Menéndez C; Simón-Rueda A; Mateos E; Cervero M; Spivak AM; Planelles V; Torres M; García-Gutiérrez V; et al. (Frontiers in pharmacology, 2024)